Divis Laboratories Q4 Results
- BSE: 532488
- NSE: DIVISLAB
- ISIN: INE361B01024
- Sector: Biotechnology & Drugs
BSE
5,463.9
25.65 (0.47%)
25.65 (0.47%)Volume8.26 K
Updated: Thu 12 Sep, 2024 | 14:25:36
NSE
5,456.9517.65 (0.32%)
17.65 (0.32%)Volume3.94 L
Updated: Thu 12 Sep, 2024 | 14:10:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Divis Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 2,303.00 | 1,707.68 | 24.15% | 1,950.77 | 18.06% |
| Selling/ General/ Admin Expenses Total | 297.00 | 238.88 | 10.82% | 257.64 | 15.28% |
| Depreciation/ Amortization | 95.00 | 86.77 | 0.00% | 87.02 | 9.17% |
| Other Operating Expenses Total | 373.00 | 320.97 | 1.08% | 373.75 | -0.20% |
| Total Operating Expense | 1,667.00 | 1,386.17 | 14.10% | 1,545.99 | 7.83% |
| Operating Income | 636.00 | 321.51 | 61.42% | 404.78 | 57.12% |
| Net Income Before Taxes | 713.00 | 435.63 | 45.81% | 466.48 | 52.85% |
| Net Income | 538.00 | 306.80 | 50.28% | 320.97 | 67.62% |
| Diluted Normalized EPS | 20.25 | 11.56 | 50.00% | 12.09 | 67.53% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Bajaj Housing Finance IPO allotment to be finalised today; latest GMP, step-by-step guide to check status
3 min read10:35 AM IST - Markets
02PN Gadgil Jewellers IPO day 3: GMP, review, subscription status, other details. Buy or not?
5 min read01:53 PM IST - Markets
03Shree Tirupati Balajee IPO listing date today; GMP, experts indicate strong debut of shares on BSE, NSE
4 min read07:30 AM IST